Unique ID issued by UMIN | UMIN000054190 |
---|---|
Receipt number | R000060425 |
Scientific Title | Investigating well-being after applying the Zenological mindfulness approach to somatic symptom disorder: a randomized controlled trial. |
Date of disclosure of the study information | 2024/04/18 |
Last modified on | 2024/10/19 06:26:59 |
Investigating self-esteem after applying the Zen-based Cognitive Behavioral Therapy for somatic symptom disorder: a randomized controlled trial
RCT Study on Zen-Based Cognitive Behavioral Therapy
Investigating well-being after applying the Zenological mindfulness approach to somatic symptom disorder: a randomized controlled trial.
Zen-based CBT by RCT
Japan |
Somatic Symptom Disorder
Psychiatry |
Others
NO
The purpose of this study is to investigate group cognitive-behavioral therapy (CBT) incorporating Zen-based mindfulness for somatic symptom disorder (SSD). The superiority of the intervention group over the control group will be evaluated in a randomized controlled trial.
Efficacy
Exploratory
Pragmatic
Not applicable
PHQ 15 (Patient Health Questionnaire 15), SSD 12 (The Somatic Symptom Disorder, B Criteria Scale)
PHQ-9 (Patient Health Questionnaire-9), GAD-7 (Generalized Anxiety Disorder-7), VAS (Visual analog Scale), PCS (Pain Catastrophe Scale), EQ-5D-5L, SHAI (Short Health Anxiety Inventory), SIUS (The Short Intolerance of Uncertainty Scale) and others
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Behavior,custom |
Cognitive Behavioral Group Therapy
Treatment as usual
18 | years-old | <= |
90 | years-old | > |
Male and Female
The subjects will be those who have been diagnosed with somatic and related symptoms using DSM5, who have given a written explanation of the purpose of the study and the benefits and disadvantages of participating in the study, and who have given their consent to the study. The subjects of this study must be at or above 18 years of age.
(1)Those who have insufficient ability to speak and understand Japanese.
(2)Persons undergoing other professional psychotherapy or clinical trials
(3)Other patients who are deemed inappropriate by the doctor in charge.
108
1st name | Toshiyuki |
Middle name | |
Last name | Tominaga |
Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Department of Psychiatry, Graduate School of Medical Science
602-8566
465 Kajii-cho Kawaramachi Hirokoji Kamigyo-ku, Kyoto Japan
0752515612
totomi@koto.kpu-m.ac.jp
1st name | Toshiyuki |
Middle name | |
Last name | Tominaga |
Kyoto Prefectural University of Medicine
Department of Psychiatry, Graduate School of Medical Science
6168186
465 Kajii-cho Kawaramachi Hirokoji Kamigyo-ku, Kyoto Japan
0752515612
totomi@koto.kpu-m.ac.jp
Kyoto Prefectural University of Medicine
Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Japanese Governmental office
Japan
Medical Ethics Review Board, Kyoto Prefectural University of Medicine
465 Kajii-cho Kawaramachi Hirokoji Kamigyo-ku, Kyoto Japan
0752515111
rinri@koto.kpu-m.ac.jp
NO
京都府立医科大学附属病院(京都府)
2024 | Year | 04 | Month | 18 | Day |
Unpublished
Preinitiation
2024 | Year | 04 | Month | 18 | Day |
2024 | Year | 09 | Month | 18 | Day |
2024 | Year | 10 | Month | 19 | Day |
2027 | Year | 03 | Month | 31 | Day |
2024 | Year | 04 | Month | 18 | Day |
2024 | Year | 10 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060425